Effects of Genetic Polymorphism of CYP2B6 and UGT1A9 and Sex Differences on Pharmacokinetics of Propofol

Journal of St. Marianna University
doi 10.17264/stmarieng.6.183
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Marianna University Society of Medical Science

Related search

Sex and the Single Nucleotide Polymorphism: Exploring the Genetic Causes of Skeletal Sex Differences

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2012English

Effect of Cyp2d6 Genetic Polymorphism on the Pharmacokinetics of Multiple-Dose Metoclopramide

Clinical Therapeutics
Pharmacology
2015English

Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects

Clinical Pharmacokinetics
Pharmacology
2018English

Sex and Genetic Differences in the Effects of Acute Diesel Exhaust Exposure on Inflammation and Oxidative Stress in Mouse Brain

Toxicology
Toxicology
2016English

Sex Differences in Genetic Architecture of Complex Phenotypes?

PLoS ONE
Multidisciplinary
2012English

Comparative Pharmacokinetics and Pharmacodynamics of the New Propofol Prodrug GPI 15715 and Propofol Emulsion: Retraction

Anesthesiology
AnesthesiologyPain Medicine
2010English

The Relationship Between Clinical Pharmacokinetics of Aripiprazole and CYP2D6 Genetic Polymorphism: Effects of CYP Enzyme Inhibition by Coadministration of Paroxetine or Fluvoxamine

European Journal of Clinical Pharmacology
MedicinePharmacology
2011English

Sex Differences in Atherosclerosis and Exercise Effects

Linköping University Medical Dissertations
2019English

Sex Differences and Effects of Cocaine on Excitatory Synapses in the Nucleus Accumbens

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy